Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Norepinephrine in Traumatic Hemorrhagic Shock
NCT07053163Completed
- Sponsor
- Tanta University
- Start
- Aug 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of norepinephrine in hemorrhagic shock (2 arms), sponsored by Tanta University. Primary endpoint: Mortality at 24 hours. Started Aug 2024; status: completed.
02
Drugs
norepinephrine
03
Conditions
hemorrhagic shock
Beyond the preview
Go deeper on NCT07053163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07053163.